Vial labeled Thymalin on a laboratory table beside an open notebook and microscope, representing thymalin peptide research for immune system support and immune dysfunction studies.

Thymalin is a biologically active peptide that's generated significant interest in recent years due to its immunomodulatory effects. Derived from the thymus gland, the peptide was first discovered and characterised in 1977; however, it was only recently that scientists began to investigate the compound as a treatment for autoimmune diseases and immunodeficiency conditions. It even has the potential to support ageing immune systems, although evidence in this area remains preliminary.

Initial research appears to show that thymalin acts directly on the thymus gland, mimicking naturally occurring peptides. The thymus gland is responsible for T-cell development (a crucial type of lymphocyte). Central to the adaptive immune system, supporting thymus function could help activate more T cells, restoring immune function in otherwise compromised individuals.

While the early results look promising, further research into the regenerative effects of thymalin is needed. That being said, the peptide is already being used or investigated in some clinical settings to treat some conditions related to immune deficiency, chronic infections, and autoimmune disorders.

Key Takeaways

  • Thymalin is a thymus-derived peptide that has been studied for its potential role in supporting immune function and T-cell development.

  • Research suggests thymalin may help regulate immune responses and influence inflammatory pathways, although more high-quality clinical trials are needed.

  • Preliminary studies have investigated thymalin in immune dysfunction, autoimmune conditions, age-related immune decline, and COVID-19 recovery support.

  • Early research has explored potential healthy ageing benefits, but current evidence is not strong enough to confirm anti-ageing or lifespan-extending effects.

  • Thymalin is distinct from thymulin and thymulin analogues, and findings from those compounds should not automatically be applied to thymalin.

What is Thymalin?

Thymalin is a polypeptide medication that’s produced synthetically for medical research and treatment. Derived from the thymus gland, this peptide compound acts directly on the thymus gland, stimulating enhanced thymic activity and increasing the production of particular white blood cells. [1]

To understand thymalin, we must first understand the thymus gland. Located in the upper chest, this gland orchestrates the development and maturation of a specialist class of white blood cells called T lymphocytes or T cells. These cells are the mainstay of the adaptive immune system, detecting pathogenic antigens and responding in a well-coordinated defense. [2]

The use of thymalin peptide in clinical treatments has shown promising results in improving the function of T-cells. By stimulating the thymus gland and enhancing the production of these immune cells, thymalin helps in boosting the body’s defense mechanisms, making it particularly beneficial for patients suffering from various immune disorders, including those who are immunocompromised. [3] The treatment has been researched and used extensively in Russia and other countries, where it is recognized as a potential tool for immune modulation. [1] [3]

Thymalin peptide therapy is often used to treat immune dysfunctions and assist patients with weakened immune systems, including those recovering from severe infections like COVID-19. The therapeutic effects of thymalin peptide are attributed to its ability to increase the number of functional immune cells, which in turn aids in quicker recovery and reduces the severity of infections, although evidence for these applications continues to be evaluated. [4]

For readers new to peptide therapies, understanding what peptides are and how they work can provide useful background before exploring compounds such as thymalin.

How Does Thymalin Work?

The molecular mechanism behind thymalin’s immunoprotective action is due to the effects of short peptides in its composition. These short peptides bind to double-stranded DNA and/or histone proteins, regulating gene expression, synthesising immune system proteins, stimulating stem cell differentiation, and activating gerontogenes. [5]

Taken together, available research suggests that thymalin may increase and accelerate the process of T cell development. Indeed, as one study found, thymalin reduced the expression of CD44 and CD117 by 2-3 times and increased the expression of CD28 by 6.8 times. As the authors concluded, “This indirectly indicates that thymalin stimulated differentiation of CD117 cells into mature CD28 T lymphocytes.” [3]

Other studies have noted an anti-inflammatory component to its mechanism of action. Thymalin was heavily investigated for COVID-19, finding that thymalin treatment normalized proinflammatory cytokine levels, preventing the deleterious “cytokine storm” present in some COVID-19 patients. [6]

Positive Effects of Thymalin

Thymalin, as an immunomodulatory agent, is primarily used or investigated to support failing or diminished immune systems. During the COVID-19 pandemic, thymalin was heavily investigated as a potential treatment, reigniting the search for medical uses despite over three decades without success. [4]

Because COVID-19 led to lower levels of helper T cells, suppressor T cells, and regulatory T cells (especially in severe cases), thymalin was suggested as a possible solution. The compound also has been investigated for its potential role in modulating inflammatory responses associated with severe COVID-19 [4]

Some preliminary clinical studies have reported that Thymalin was found to reduce mortality in COVID-19 patients as well as counteract the low levels of T cells seen in immunodeficiency and autoimmune diseases. It also has a protective role in the lungs, enhancing anti-inflammatory and inhibiting proinflammatory cytokines. [4]

In addition to these COVID-19-related effects, thymalin has the following benefits:

  • Potential Immune Support. The most important proposed effect of thymalin is its potential to enhance the existing immune system, particularly the adaptive response. It, therefore, has an important function in immune disorders like HIV, which suppress the immune system, or autoimmune diseases such as rheumatoid arthritis. The treatment has also been used as an adjunct therapy in clinical practices for patients infected with influenza, hepatitis B and C viruses, herpes simplex, and HIV. Although evidence quality varies depending on the condition being studied. [7]
  • Potential to Increase Lifespan. The anti-ageing properties have been proposed in some research, potentially including improving skin elasticity and reducing the appearance of wrinkles. In the longest human clinical trial involving therapeutic peptides, 266 patients aged over 60 were given either nothing, Epithalon, thymalin, or both. The results found that patients taking some form of thymalin saw a reduction in acute respiratory disease, mortality, heart disease, high blood pressure, and osteoporosis compared to the control (Fig 1.). In longevity discussions, thymalin is often mentioned alongside other best peptides for anti-aging that are being investigated for healthy ageing and age-related decline. [8]
  • Anti-Inflammatory Properties. Due to COVID-19, thymalin’s ability to dampen down the immune system’s response to infections once again became common knowledge. In 2008, thymalin was noted to prevent the accumulation of several proinflammatory cytokines, including IL-1 beta, IL-2, IL_6, TNF-alpha, interferon-gamma, and anti-inflammatory cytokine IL-10. This was instrumental in counteracting the cytokine storm present in severe COVID-19 cases. [9]
  • Pain Reduction. Some evidence exists suggesting that thymalin (or, in some studies, thymulin analogues) can provide analgesic benefits, although findings involving thymulin analogues should not be considered direct evidence for thymalin itself. In a 2002 study, PAT (peptide analogue of thymalin) demonstrated an equal analgesic effect compared to potent medications like dexamethasone and indomethacin. As the paper concluded, “The anti-hyperalgesic and anti-inflammatory effects of PAT can be attributed, at least partially, to the downregulation of proinflammatory mediators.” [10]

Fig. 1 Effect of thymalin and epithalamin on the state of immune, endocrine systems, and metabolism as measured by the homeostasis stability coefficient, a measure of bodily performance where 100% HSC corresponded to the norm.  * – P<0.01; ** – P<0.001, as compared to the baseline level for this group; # – P<0.001, as compared to the analogous index for the control group.

First and foremost, thymalin is known as an immunomodulator – even its analgesic effects are, in part, related to this effect. However, recent research has indicated several possible benefits. [10]

Other surprising consequences of thymalin include:

  • Anti-Hair Loss. According to one study, thymalin and zinc were reported to show potential for restoring lost hair. The mixture is applied to the scalp and any bald patches, forcing the hair to enter the anagen phase of hair growth. Indeed, thymic peptides naturally exert a hair growth-modulatory effect, triggering hair growth. In one study, zinc-thymalin saw significant improvements in hair growth in regions with previous “absent hair.” Researchers have also investigated several compounds featured in our guide to the best peptides for hair growth. [11]
  • Antitumour Agent. Initial results from a Russian study noted “pronounce antitumour effects” from thymalin against a transplanted sarcoma in male rates. [12] Another study in females with advanced cervical carcinoma also noted that thymalin immunotherapy and radiotherapy worked better than radiotherapy alone. [13] However, a Cochrane review of all thymic peptides found no evidence of antitumour effects. [14]

Thymalin Dosages

Thymalin dosages vary significantly from study to study. Due to limited long-term data, we haven’t got a reliable estimate of dosage that’s safe for several years.

Usually, thymalin has been administered in published studies and clinical protocols in a dosage range of 1 mg to 10 mg either intramuscularly or subcutaneously every day for a set period, e.g., 10 days. For example, in a COVID-19 study, thymalin was given in the form of 10 mg/2 mL 0.9% NaCl intramuscular injections every day for 10 days. [4]

According to Russian pharmaceutical manufacturer Cosmic Nootropic ( Discount Code EP10), the correct dosages by age are as follows:

The information below reflects reported study protocols and manufacturer materials and should not be interpreted as medical advice, treatment recommendations, or guidance for self-administration.

Age Dosage
Up to 1 year old 0.5-1 mg per day
1-3 years old 1-2 mg per day
4-6 years old 1-3 mg per day
7-14 years old 1-5 mg per day
Adults 1-20 mg per day

The medication should be given every day intramuscularly or subcutaneously for 3-10 days and can only be repeated (if necessary) after 1 to 6 months. Similar dosage protocols are also reported by RuPharma, which also notes that when used for preventative purposes, the recommended dosage is 1-10 mg for adults  3-5 days.

However, it should be noted that the efficacy of thymalin is heavily dependent on the presence of zinc. If a patient experiences a zinc deficiency, then thymalin will be substantially less effective.

Potential side effects of thymalin include restlessness (akathisia) and irritability or mood instability. Compared to other peptides, it has an incredibly mild side effect profile. That being said, it is not advised for women who are breast-feeding or pregnant. Always consult your physician before starting any new supplement or regimen. Those looking to calculate concentrations, reconstitution amounts, or injection volumes may find our peptide calculator useful.

The Role of Thymalin Peptide in Treating COVID-19 Patients

Thymalin has been explored as a potential treatment for COVID-19, especially in the context of immune dysfunction and recovery from severe symptoms. COVID-19 remains an ongoing health issue worldwide, although the World Health Organization ended the Public Health Emergency of International Concern (PHEIC) in May 2023. In particular, severe cases of COVID-19 often lead to immune dysregulation, where the body’s immune system either overreacts or fails to respond appropriately, causing severe symptoms like respiratory distress and chest complications. [4] [16] [17]

Some preliminary studies have suggested that thymalin may support recovery in COVID-19 patients by helping to restore aspects of normal immune function. Studies have indicated that thymalin may contribute to the normalization of immune cell activity, reducing the inflammatory response associated with severe infections. As COVID-19 often leads to a disruption in immune function, researchers have investigated whether thymalin may help support immune cell responses. [4] [16]

Early research has suggested potential benefits in patients with severe COVID-19, particularly in patients who experience chronic respiratory problems or other immune-related issues. In a study published in a medical journal, thymalin peptide was associated with faster recovery among participants studied, with a noticeable reduction in symptoms and improvement in lung function. [4] [16]

The Future of Thymalin Peptide Use

As research into thymalin peptide continues to evolve, its potential applications in treating various diseases, including immune dysfunction and COVID-19, are becoming more apparent. The growing body of clinical evidence has prompted further investigation into its use as an adjunctive therapy for patients suffering from severe infections, autoimmune disorders, and immune-related diseases. While COVID-19 remains an ongoing health issue worldwide, despite the WHO ending the Public Health Emergency of International Concern (PHEIC) in May 2023, thymalin continues to be investigated for potential applications in viral infections and immune-related conditions. [3] [4] [17]

The growing body of clinical evidence has prompted further investigation into its use as an adjunctive therapy for patients suffering from severe infections, autoimmune disorders, and immune-related diseases. This growing interest mirrors research examining how peptides and stem cells work together in regenerative medicine.

Thymalin’s ability to modulate immune responses and help restore immune function has made it an area of interest for researchers studying compromised immune systems. Additionally, its potential benefits in treating conditions such as COVID-19, respiratory distress, and other immune-related complications have encouraged further research into its possible role in clinical medicine. [4]

As more clinical trials are conducted and additional research emerges, thymalin peptide is likely to become a key player in the treatment of immune dysfunction, with potential applications in various therapeutic areas, from chronic disease management to post-viral recovery. For patients struggling with weakened immune systems, thymalin peptide may offer hope for improved recovery and improved quality of life.

Final Thoughts

Thymalin presents a powerful therapy for bolstering immune systems in people with immunodeficiency, autoimmune disease, or age-related immune decline. This peptide has been the subject of research for several decades; however, it was during the COVID-19 pandemic that it reemerged as a potential treatment, with researchers investigating its possible effects on adaptive immune function and inflammatory signalling pathways associated with severe infection.

Several studies have found that thymalin works directly on the thymus gland, mirroring similar natural peptides. Due to a complex interplay of receptors and molecules, thymalin may increase the development and maturation of T lymphocytes. It also appears to influence inflammatory responses, with some studies reporting changes in proinflammatory cytokine levels.

Overall, thymalin’s role in immunomodulation and its broad potential applications make it an intriguing candidate for further study and clinical use. Its ability to support immune function, reduce inflammation, and even provide anti-ageing benefits highlights its versatility. Continued research and clinical trials will be crucial in understanding the full spectrum of its benefits and potential side effects.

With growing interest in peptide therapies, thymalin continues to attract research interest for its possible role in immune-related conditions and healthy ageing. It is also part of a broader category of peptide bioregulators being studied for their potential effects on longevity and age-related decline.

FAQs

What Is Thymalin Peptide Used For?

Thymalin is primarily discussed as an immunomodulatory peptide that may support immune function in cases of immune dysfunction, age-related immune decline, and certain inflammatory conditions. Research has also explored its role in post-infection recovery and broader immune system support.

How Does Thymalin Affect The Immune System?

Thymalin is believed to act on the thymus gland, which plays a central role in the development and maturation of T lymphocytes (T cells). By supporting thymic activity, thymalin may help improve adaptive immune responses and promote healthier immune cell function. [15]

Can Thymalin Help With Age-Related Immune Decline?

Thymalin has attracted interest for its potential role in supporting ageing immune systems, especially because thymus function tends to decline with age. Some research suggests it may help maintain immune balance and improve resilience in older adults, although more long-term data is still needed. [15]

Is Thymalin Being Studied For COVID-19 Recovery?

Yes, thymalin has been investigated for its possible role in supporting immune recovery in COVID-19 patients, particularly in cases involving immune dysregulation and excessive inflammation. Research has explored whether it may help normalize immune responses and reduce complications linked to severe infection. [16]

What Is The Typical Thymalin Dosage In Studies?

Published studies and product references have used a range of 1 mg to 10 mg per day, often given intramuscularly or subcutaneously for several days, depending on the protocol. However, dosing can vary significantly between studies, and there is no universally established long-term standard.

Does Thymalin Have Side Effects?

Thymalin is generally described as having a mild side effect profile compared to many other compounds, but side effects may still occur. Reported concerns include restlessness, irritability, or mood-related changes, and it is typically not recommended during pregnancy or breastfeeding without medical guidance.

Is Thymalin Approved Everywhere For Immune Treatment?

No, thymalin is not uniformly approved or widely used across all countries. Much of the clinical experience and therapeutic use has been reported in Russia and certain other regions, while in many places it remains more of a research-focused or limited-use compound rather than a mainstream treatment.

Sourcing

USA

USA Map Outline
  • LIMITLESS LIFE NOOTROPICS aka Biotech
  • Use Discount Code: EP20

    EP20
    COPY CODE
    Copied EP20
  • SCANTIFIX
  • Use Discount Code: Exploringpeptides

    Exploringpeptides
    COPY CODE
    Copied Exploringpeptides

Canada

Canada Map Outline
  • BIOSLAB
  • Use Discount Code: EP10

    EP10
    COPY CODE
    Copied EP10
  • SCANTIFIX
  • Use Discount Code: Exploringpeptides

    Exploringpeptides
    COPY CODE
    Copied Exploringpeptides

Europe

Europe Map Outline
  • DNLABResearch
  • Use Discount Code: EP15

    EP15
    COPY CODE
    Copied EP15

Australia

Australia Map Outline
  • LVLUPHEALTH
  • Use Discount Code: Exploringpeptides

    Exploringpeptides
    COPY CODE
    Copied Exploringpeptides
  • SCANTIFIX
  • Use Discount Code: Exploringpeptides

    Exploringpeptides
    COPY CODE
    Copied Exploringpeptides

References

[1] Khavinson VK, Linkova NS, Chalisova NI, Ivko OM. The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity. Biol Bull Rev. 2021;11(4):377–82. doi: 10.1134/S2079086421040046. Epub 2021 Aug 16. PMCID: PMC8365293.

[2] Sauls RS, McCausland C, Taylor BN. Histology, T-Cell Lymphocyte. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535433/

[3] Khavinson VK, Linkova NS, Kvetnoy IM, Polyakova VO, Drobintseva AO, Kvetnaia TV, Ivko OM. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bull Exp Biol Med. 2020 Nov;170(1):118-122. doi: 10.1007/s10517-020-05016-z. Epub 2020 Nov 25. PMID: 33237528; PMCID: PMC7686446.
[4] Kuznik B.I., Smolyakov Y.N., Shapovalov K.G., Tereshkov P.P., Konnov V.A., Chalisova N.I. Prognosis of immune state following basic therapy and thymalin treatment in patients with severe COVID-19 infection // Russian Journal of Immunology. - 2023. - Vol. 26. - N. 1. - P. 49-56. doi: 10.46235/1028-7221-1209-POI
[5] Kuznik, B., Khavinson, V., Shapovalov, K. et al. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients. Adv Gerontol 11, 368–376 (2021). https://doi.org/10.1134/S2079057021040068
[6] Novoselova, E.G., Lunin, S.M., Glushkova, O.V., Khrenov, M.O., Parfenyuk, S.B., Zakharova, N.M. and Fesenko, E.E. (2018). Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation. PLOS ONE, 13(5), p.e0197601. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0197601
[7] Lukyanov, S. A., Kuznik, B. I., Shapovalov, K. G., Khavinson, V. K., Smolyakov, Y. N., Tereshkov, P. K., Shapovalov, Y. K., Konnov, V. A., & Magen, E. (n.d.). Thymalin as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2. Chita State Medical Academy, Chita, Russia. https://doi.org/10.23937/2378-3672/1410055
[8] Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003 Jun-Aug;24(3-4):233-40. PMID: 14523363.
[9] Lunin SM, Khrenov MO, Novoselova TV, Parfenyuk SB, Novoselova EG. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein Hsp70 in inflammation-bearing mice. Immunol Invest. 2008;37(8):858-70. doi: 10.1080/08820130802447629. PMID: 18991101.

[10] Safieh-Garabedian B, Dardenne M, Pléau JM, Saadé NE. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. British Journal of Pharmacology. 2002 Jul;136(6):947-955. DOI: 10.1038/sj.bjp.0704793. PMID: 12110619; PMCID: PMC1573422.

[11] Vickers, E. R. (2017). An analysis of the safety and efficacy of topical Zinc-Thymulin to treat androgenetic alopecia. Hair Therapy & Transplantation, 7(1). https://doi.org/10.4172/2167-0951.1000147

[12] Zhukova GV, Schikhlyarova AI, Barteneva TA, Shevchenko AN, Zakharyuta FM. Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo. Bull Exp Biol Med. 2018 May;165(1):80-83. doi: 10.1007/s10517-018-4104-z. Epub 2018 May 24. PMID: 29797130.

[13] Vishnevskaya, E.E., Khavinson, V.Kh., & Nikolaeva, D.V. (1991). Application of thymalin for complex treatment of advanced cervical carcinoma. Voprosy Onkologii, (1), 86-90.

[14] Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M. Thymic peptides for treatment of cancer patients. Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003993. doi: 10.1002/14651858.CD003993.pub3. PMID: 21328265; PMCID: PMC6481824.

[15] Khavinson VK, Linkova NS, Chalisova NI, Ivko OM. The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity. Biol Bull Rev. 2021;11(4):377–82. doi: 10.1134/S2079086421040046. Epub 2021 Aug 16. PMCID: PMC8365293.

[16] Kuznik B, Khavinson V, Shapovalov K, Linkova N, Lukyanov S, Smolyakov Y, Tereshkov P, Shapovalov Y, Konnov V, Tsybikov N. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients. Adv Gerontol. 2021;11(4):368–76. doi: 10.1134/S2079057021040068. Epub 2021 Dec 9. PMCID: PMC8654498.

[17] WHO COVID-19 PHEIC statement: Supports updating “ongoing pandemic” wording to reflect that WHO ended the COVID-19 PHEIC/emergency phase in May 2023 while COVID-19 remains a health concern.